PLX Total Non-Current Assets
Protalix Biotherapeutics Inc · Total Non-Current Assets
PLX Total Non-Current Assets
Latest reported$18.12Mperiod ending
PLX Quarterly Non-Current Assets ($0.00 → $18.12M)
Quarterly total non-current assets
High-resolution chart · PNG
PLX total non-current assets history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Assets (USD) |
|---|---|
| 18,116,000 | |
| 15,980,000 | |
| 15,673,000 | |
| 15,762,000 | |
| 13,001,000 | |
| 13,378,000 | |
| 13,339,000 | |
| 13,710,000 | |
| 14,173,000 | |
| 14,421,000 | |
| 14,502,000 | |
| 14,951,000 | |
| 14,841,000 | |
| 11,158,000 | |
| 10,907,000 | |
| 10,949,000 | |
| 10,940,000 | |
| 11,849,000 | |
| 11,999,000 | |
| 12,258,000 | |
| 12,281,000 | |
| 12,094,000 | |
| 12,211,000 | |
| 11,978,000 | |
| 17,500,000 | |
| 25,109,000 | |
| 12,913,000 | |
| 13,290,000 | |
| 13,644,000 | |
| 13,703,000 | |
| 8,148,000 | |
| 9,857,000 | |
| 8,669,000 | |
| 9,109,000 | |
| 9,563,000 | |
| 9,905,000 | |
| 10,109,000 | |
| 10,309,000 | |
| 10,380,000 | |
| 10,826,000 | |
| 11,219,000 | |
| 11,041,000 | |
| 11,372,000 | |
| 11,616,000 | |
| 12,086,000 | |
| 12,464,000 | |
| 12,950,000 | |
| 13,587,000 | |
| 14,287,000 | |
| 14,855,000 | |
| 15,430,000 | |
| 15,956,000 | |
| 16,374,000 | |
| 17,048,000 | |
| 17,557,000 | |
| 17,798,000 | |
| 18,414,000 | |
| 18,627,000 | |
| 19,314,000 | |
| 20,547,000 | |
| 20,693,000 | |
| 18,669,000 | |
| 18,396,000 | |
| 16,707,000 | |
| 15,501,000 | |
| 15,452,000 | |
| 15,261,000 | |
| 12,826,000 | |
| 11,108,000 | |
| 8,937,000 | |
| 7,422,000 | |
| 6,930,000 | |
| 6,540,000 | |
| 5,948,000 | |
| 4,970,000 | |
| 4,165,000 | |
| 3,594,000 | |
| 3,218,000 | |
| 2,697,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 43,258 | |
| 49,352 | |
| 55,349 | |
| 61,250 | |
| 67,056 | |
| 149,240 |